C-TIL051

· AbelZeta Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for C-TIL051, covering 2026-01-05 to 2026-01-05. Get the full timeline:

Most recent: Clinical Trial Update: C-TIL051 in Non-Small Cell Lung Cancer [Phase 1]